These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 3520936)

  • 1. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification.
    Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Huang JY; Kristensen P; Danø K
    Thromb Haemost; 1986 Apr; 55(2):206-12. PubMed ID: 3520936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological relationship between the fast-acting plasminogen activator inhibitors from plasma, blood platelets and endothelial cells demonstrated with a monoclonal antibody against an inhibitor from placenta.
    Philips M; Juul AG; Thorsen S; Selmer J; Zeuthen J
    Thromb Haemost; 1986 Apr; 55(2):213-7. PubMed ID: 2424117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator.
    Astedt B; Lecander I; Brodin T; Lundblad A; Löw K
    Thromb Haemost; 1985 Feb; 53(1):122-5. PubMed ID: 3922076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies against human high molecular weight urinary urokinase: application for affinity purification of urinary prourokinase.
    Wojta J; Kirchheimer JC; Turcu L; Christ G; Binder BR
    Thromb Haemost; 1986 Jun; 55(3):347-51. PubMed ID: 3092391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoaffinity purification of HTC rat hepatoma cell plasminogen activator-inhibitor-1.
    Zeheb R; Rafferty UM; Rodriguez MA; Andreasen P; Gelehrter TD
    Thromb Haemost; 1987 Dec; 58(4):1017-23. PubMed ID: 3127913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.
    Andreasen PA; Christensen TH; Huang JY; Nielsen LS; Wilson EL; Danø K
    Mol Cell Endocrinol; 1986 May; 45(2-3):137-47. PubMed ID: 3011558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Isolation and characteristics of urokinase-type plasminogen activator from a culture of human embryo lung fibroblasts].
    Shevelev AIa; Barshevskaia TN; Belogurov AA; Kratasiuk GA; Goriunova LE
    Mol Biol (Mosk); 1986; 20(3):778-88. PubMed ID: 3088432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody to human 66,000 molecular weight plasminogen activator from melanoma cells. Specific enzyme inhibition and one-step affinity purification.
    Nielsen LS; Hansen JG; Andreasen PA; Skriver L; Danø K; Zeuthen J
    EMBO J; 1983; 2(1):115-9. PubMed ID: 11894897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human articular cartilage contains an inhibitor of plasminogen activator.
    Yamada H; Stephens RW; Nakagawa T; McNicol D
    J Rheumatol; 1988 Jul; 15(7):1138-43. PubMed ID: 3139880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.
    Andreasen PA; Nielsen LS; Kristensen P; Grøndahl-Hansen J; Skriver L; Danø K
    J Biol Chem; 1986 Jun; 261(17):7644-51. PubMed ID: 3086313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody that recognizes the receptor binding region of human urokinase plasminogen activator.
    Nolli ML; Corti A; Soffientini A; Cassani G
    Thromb Haemost; 1986 Oct; 56(2):214-8. PubMed ID: 2433787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and characterization of monoclonal antibodies against tissue-type plasminogen activator.
    Ding H; Wang JY; Song HY
    Chin J Biotechnol; 1990; 6(3):223-7. PubMed ID: 2129498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of two monoclonal antibodies against human tissue-type plasminogen activator.
    Schleef RR; Sinha M; Loskutoff DJ
    Thromb Haemost; 1985 Apr; 53(2):170-5. PubMed ID: 4040658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and characterization of monoclonal antibodies against human IgG in Balb/c mouse.
    Majidi J; Baradaran B; Hassan ZM; Mostafaie A
    Hum Antibodies; 2005; 14(1-2):1-5. PubMed ID: 16424594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble urokinase receptor from fibrosarcoma HT-1080 cells.
    Lau HK; Kim M
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):473-8. PubMed ID: 7841301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of monoclonal antibodies in the diagnosis of fibrinolysis].
    Wojta J; Korninger C; Kirchheimer J; Hattey E; Turcu L; Binder BR
    Wien Klin Wochenschr; 1985 Mar; 97(5):244-8. PubMed ID: 4039506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of high and low molecular weight plasminogen activator inhibitor 1 from fibrosarcoma cell-line HT 1080 conditioned medium.
    Lindahl T; Wiman B
    Biochim Biophys Acta; 1989 Feb; 994(3):253-7. PubMed ID: 2493266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of both type 1 and type 2 plasminogen activator inhibitors in human cells.
    Schleef RR; Wagner NV; Loskutoff DJ
    J Cell Physiol; 1988 Feb; 134(2):269-74. PubMed ID: 3257967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human hepatoma cell line plasminogen activator.
    Levin EG; Fair DS; Loskutoff DJ
    J Lab Clin Med; 1983 Oct; 102(4):500-8. PubMed ID: 6311924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A plasminogen activator inhibitor-2 from a promyelocytic leukemia cell line, PL-21, binds to the carboxy-terminal chain of plasminogen activators.
    Takeuchi T; Niiya K; Kubonishi I; Miyoshi I
    Thromb Haemost; 1990 Apr; 63(2):259-64. PubMed ID: 2363126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.